almost
nineti
year
viru
caus
disastr
influenza
epidem
identifi
million
peopl
still
affect
annual
sever
symptom
die
furthermor
highli
virul
strain
still
appear
result
local
epidem
global
pandem
bird
flu
swine
flu
situat
frustrat
time
mankind
success
tackl
viral
maladi
smallpox
measl
polio
develop
effici
drug
vaccin
diseasecaus
pandemiccaus
agent
inde
signific
advanc
made
understand
influenza
major
mechanist
aspect
viral
infect
process
viral
life
cycl
reveal
import
progress
made
vaccin
therapi
howev
fact
influenza
still
prevail
demonstr
unambigu
pain
drug
vaccin
effici
vaccin
therapi
diseas
multipl
reason
ineffici
vaccin
therapi
exist
influenza
virus
high
mutat
rate
seem
primari
hurdl
develop
effici
effect
vaccin
mutat
could
also
account
rapid
evolut
drugresist
influenza
strainsb
given
influenza
rna
viru
rna
polymeras
lack
proofread
activ
errorpron
also
influenza
abl
infect
varieti
host
increas
chanc
mutat
genet
chang
viru
anoth
reason
could
simpli
stem
fact
still
fulli
understand
critic
step
infect
cycl
thoroughli
unravel
function
mechan
action
sever
influenza
viral
protein
latter
aspect
approach
varieti
experiment
system
primarili
cell
line
mammalian
avian
anim
model
fact
year
massiv
effort
still
effici
therapi
comprehens
vaccin
combin
mani
question
regard
influenza
patholog
still
open
motiv
investig
tri
new
case
seemingli
irrelev
experiment
model
inde
model
singlecel
organ
yeast
invertebr
drosophila
melanogast
drosophila
aquat
vertebr
zebrafish
appear
legitim
studi
humaninfect
viru
provid
nevertheless
advantag
contribut
understand
import
aspect
viralhost
interact
viral
replic
advantag
uniqu
system
deriv
fact
lower
organ
evolutionari
tree
consequ
much
simpler
rel
mammal
advantag
deriv
simplic
widespread
use
organ
basic
biolog
research
led
gener
sophist
technolog
librari
mutant
inform
system
readili
avail
system
also
permiss
effici
rapid
genet
screen
drug
screen
need
genet
screen
largescal
approach
essenti
identifi
numer
effect
viru
host
system
achiev
close
function
structur
connect
biochem
machineri
host
addit
simpl
anim
model
anoth
less
use
system
influenza
research
primari
human
tissu
cultur
relev
cell
obviou
may
replac
mani
studi
use
cell
line
dog
mice
human
cell
line
deriv
cancer
cell
advantag
use
primari
cultur
isol
patient
use
studi
diseas
individu
level
purpos
review
draw
attent
emerg
altern
model
discuss
benefit
one
could
extract
better
comprehend
intricaci
influenza
viru
develop
tool
devis
novel
antiinfluenza
therapi
influenza
viru
belong
orthomyxovirida
famili
negativesens
singlestrand
rna
virus
caus
respiratori
diseas
three
type
influenza
virus
name
b
c
prolif
member
influenza
infect
larg
number
host
main
caus
season
pandem
influenza
genom
compos
symmetr
helix
eight
segment
number
accord
decreas
length
segment
encod
surfac
glycoprotein
haemagglutinin
ha
neuraminidas
na
matrix
protein
matrix
ion
channel
viral
rnadepend
rna
polymeras
complex
compos
nucleoprotein
np
polymeras
basic
subunit
polymeras
acid
subunit
pa
nuclear
export
protein
nepnonstructur
protein
segment
influenza
viru
strain
may
encod
second
third
polypeptid
altern
read
frame
protein
pax
function
known
immunomodulatori
modul
host
respons
viru
influenza
viru
classifi
differ
subtyp
base
ha
na
glycoprotein
haemagglutinin
neuraminidas
subtyp
known
today
subtyp
caus
epidem
human
influenza
viru
life
cycl
divid
follow
stage
host
cell
entri
uncoat
viral
ribonucleoprotein
vrnp
entri
nucleu
transcript
translat
viral
genom
vrnp
export
nucleu
viral
assembl
host
cell
bud
plasma
membran
viral
ha
bind
sialic
acid
cell
surfac
membran
result
viru
intern
via
endosom
acidif
within
endosom
assist
ion
channel
induc
viral
envelop
fuse
endosom
fusion
releas
viral
content
genet
materi
form
vrnp
viral
replic
occur
via
synthesi
positivesens
intermedi
transcript
neg
rna
posit
sens
mrna
creat
proper
platform
translat
viral
protein
viral
protein
vrnp
migrat
plasma
membran
bundl
new
virion
new
virion
bud
plasma
membran
infect
cell
influenza
viru
transmit
respiratori
droplet
caus
acut
respiratori
diseas
human
young
children
elderli
chronic
condit
like
diabet
heart
diseas
kidney
diseas
immunocompromis
patient
especi
vulner
sever
influenza
sever
influenza
may
result
complic
acut
bronchiti
secondari
bacteri
pneumonia
influenza
virus
evolv
constantli
antigen
shift
reassort
viral
segment
result
dramat
differ
virus
drift
small
antigen
chang
increas
immun
evas
due
viral
adapt
reassort
highli
virul
strain
may
appear
result
local
epidem
global
pandem
spanish
pandem
bird
flu
swine
flu
date
two
antivir
drug
class
use
avail
develop
trial
drug
avail
clinic
matrix
ion
channel
inhibitor
eg
amantadin
rimantadin
neuraminidas
na
inhibitor
eg
oseltamivir
zanamivir
emerg
resist
viru
strain
render
inhibitor
useless
also
grow
resist
na
inhibitor
mutat
found
strain
made
viru
oseltamivirresist
howev
obviou
fit
cost
virus
hold
na
resist
result
low
frequenc
mutat
year
newer
drug
favipiravir
nucleotid
analog
target
viral
polymeras
approv
japan
baloxavir
marboxil
capdepend
endonucleas
inhibitor
approv
japan
us
pimodivir
inhibitor
preapprov
access
fda
new
drug
test
clinic
trial
includ
remov
sialic
acid
receptor
glycan
structur
nitazoxamid
interfer
ha
assembl
ha
monoclon
antibodi
potenti
drug
class
compound
call
naphthalimid
antagon
class
compound
yet
undergo
futur
develop
reach
clinic
trial
given
scarciti
effici
antiinfluenza
drug
major
strategi
prevent
control
season
influenza
epidem
annual
influenza
vaccin
programm
due
vari
effect
year
year
pandem
epidem
still
appear
vaccin
mismatch
predomin
antigen
strain
one
main
method
produc
influenza
vaccin
fertil
embryon
chicken
egg
first
circul
viru
reassort
highgrowth
strain
apuerto
vaccin
strain
select
high
growth
properti
contain
ha
na
deriv
circul
strain
select
strain
amplifi
egg
viru
harvest
inactiv
seriou
disadvantag
method
viru
becom
mismatch
due
viral
adapt
egg
cultur
affect
vaccin
efficaci
anoth
upcom
method
vaccin
product
use
cell
cultur
propag
viru
howev
far
date
one
vaccin
flucelvax
approv
fda
also
given
vaccin
produc
eggderiv
viru
strain
egg
adapt
may
still
exist
vaccin
notabl
new
experiment
model
describ
review
could
assist
understand
viru
biochemistri
physiolog
also
overcom
current
limit
vaccin
product
exampl
done
via
surfac
display
yeast
product
larg
quantiti
viral
antigen
yeast
drosophila
cell
rather
propag
viru
egg
cultur
first
anim
investig
abl
infect
human
influenza
viru
ferret
model
remain
today
yet
conveni
experiment
model
requir
rodent
includ
mice
hamster
cotton
rat
guinea
pig
becam
wide
use
pig
also
use
patholog
influenza
lung
similar
manifest
human
pig
even
suspect
intermedi
host
viru
model
evolutionarili
closer
human
therefor
consid
relev
nonhuman
primat
variou
macaqu
rhesu
pigtail
cynomolgu
squirrel
monkey
african
green
monkey
review
bouvier
et
al
thangavel
et
al
addit
avian
model
chicken
also
use
mainli
veterinari
purpos
use
mammalian
avian
model
seem
logic
first
choic
assumpt
influenza
viru
natur
infect
model
also
assum
infect
machineri
life
cycl
viru
within
model
organ
similar
human
notabl
howev
assumpt
hold
model
exampl
ferret
highli
suscept
viru
good
model
perspect
high
cost
lack
wide
avail
resourc
antibodi
limit
use
mice
influenza
viru
could
caus
diseas
mice
viru
first
adapt
speci
serial
passag
lung
thu
although
mice
wide
use
model
organ
influenza
primarili
costeffect
permiss
genet
manipul
mani
mutant
transgen
anim
avail
mice
might
ideal
model
studi
influenza
due
differ
diseas
pathogenesi
limit
infect
viral
strain
also
monkey
viru
replic
pulmonari
cell
season
strain
caus
pathogen
symptom
unless
highli
virul
viral
strain
use
thu
even
nonhuman
primat
fulli
reproduc
human
viral
infect
optim
anim
model
system
manifest
aspect
human
diseas
cours
establish
immort
cell
line
found
infect
influenza
promin
exampl
madindarbi
canin
kidney
mdck
vero
cell
human
embryon
kidney
hek
lung
epitheli
cell
addit
model
use
studi
entir
scope
infect
viral
life
cycl
new
insight
influenza
could
deriv
studi
intrins
biochem
properti
structurefunct
relationship
specif
function
viral
protein
aspect
studi
context
cellular
anim
infect
protein
may
regul
control
complex
mammalian
machineri
therefor
studi
properti
function
viral
protein
either
intrins
featur
appear
follow
interact
protein
viral
human
isol
system
includ
vitro
system
appli
influenza
protein
express
purifi
recombin
protein
differ
sourc
includ
bacteria
mammalian
cell
protein
assay
vitro
crystal
experiment
system
uniqu
viral
protein
rather
common
techniqu
biolog
research
therefor
describ
yet
studi
biochemistri
viral
protein
could
advanc
use
altern
model
discuss
review
describ
brief
current
model
elabor
new
model
madindarbi
canin
kidney
mdck
cell
line
establish
madin
darbi
shown
soon
afterward
suscept
infect
variou
strain
influenza
appar
cell
line
kidney
cell
deriv
bovin
chicken
monkey
even
human
permiss
viral
infect
support
mani
cycl
viral
replic
base
observ
mdck
cell
support
multipl
round
viru
replic
serial
passag
propos
dog
might
natur
host
viru
sinc
sever
mdck
deriv
develop
studi
influenza
vitro
primarili
altern
method
embryon
chicken
egg
influenza
viru
propag
mean
determin
viru
titer
plaqu
assay
mdck
cell
also
use
almost
paper
produc
influenza
vaccin
studi
viru
pathogenesi
replic
kinet
evalu
efficaci
antivir
drug
recent
exampl
use
mdck
cell
studi
compound
call
favipiravir
compound
abl
inhibit
plaqu
format
mdck
cell
even
hour
post
infect
hpi
apuerto
viru
also
inhibit
viral
growth
moi
activ
affect
viru
multipl
cell
treat
supernat
cell
time
lower
viru
yield
nontreat
control
dose
increas
product
infect
observ
drug
test
mice
approv
japan
treatment
influenza
infect
human
lung
adenocarcinoma
epitheli
cell
line
human
bronchial
epitheli
cell
line
wide
use
studi
influenza
interact
viral
protein
biochemistri
drug
studi
perform
largescal
screen
crispr
activ
screen
identifi
gene
inhibit
influenza
viru
infect
overexpress
cell
epitheli
cell
deriv
embryon
kidney
expos
shear
fragment
adenoviru
dna
cell
wide
use
protein
express
studi
due
eas
transfect
cell
vero
cell
kidney
cell
deriv
cercopithecu
aethiop
african
green
monkey
kidney
extens
use
virolog
research
vero
cell
studi
basic
research
regard
influenza
well
vaccin
research
review
milian
e
mous
wide
use
low
cost
small
size
eas
husbandri
mousespecif
tool
molecular
biolog
immunolog
studi
also
readili
avail
mani
inbr
laboratori
mice
also
suscept
influenza
viru
infect
howev
signific
drawback
mous
model
wild
mice
fact
suscept
influenza
express
antivir
protein
part
gtpase
famili
known
antivir
function
laboratori
viral
strain
requir
prior
adapt
mice
mani
laboratori
mice
strain
display
diseas
follow
infect
primari
human
influenza
viru
isol
part
due
prefer
human
influenza
viru
sialic
acid
receptor
surfac
host
cell
human
express
sialic
acid
receptor
upper
respiratori
tract
influenza
viru
commonli
replic
mice
express
sialic
acid
upper
lower
respiratori
tract
moreov
mice
display
clinic
sign
acut
viral
infect
exhibit
fever
unlik
human
ferret
rank
among
best
anim
model
influenza
lung
physiolog
ferret
highli
similar
human
share
mani
clinic
symptom
present
human
follow
influenza
infect
suscept
human
influenza
viru
thu
prior
adapt
viru
ferret
necessari
furthermor
viru
transmit
easili
among
ferret
recapitul
viru
spread
human
given
similar
physiolog
respons
influenza
viru
ferret
human
ferret
use
studi
influenza
protein
assess
effect
antivir
compound
amelior
diseas
progress
howev
limit
ferret
highli
suscept
infect
intramuscular
immun
rout
noninfecti
antigen
result
poor
antibodi
respons
light
import
immunogen
studi
exist
novel
vaccin
huge
drawback
use
ferret
due
similar
genet
physiolog
monkey
human
nonhuman
primat
specif
macaqu
similar
immun
respons
human
regard
influenza
infect
review
bouvier
et
al
nonhuman
primat
use
studi
highli
pathogen
viru
strain
host
cytokin
respons
believ
involv
diseas
patholog
studi
efficaci
drug
vaccin
strain
howev
high
cost
complex
husbandri
requir
ethic
issu
make
primat
less
access
routin
influenza
studi
date
transmiss
studi
perform
nhp
addit
differ
viru
bind
site
macaqu
human
avian
influenza
sinc
influenza
main
caus
respiratori
diseas
pig
anim
use
model
studi
influenza
review
rajao
et
al
due
similar
human
term
genet
anatomi
physiolog
social
behaviorswin
respiratori
tract
similar
tracheobronchi
structur
lung
physiolog
size
human
immun
system
pig
also
similar
human
fulli
understood
yet
compar
anim
model
limit
model
cost
husbandri
larger
space
need
hous
anim
compar
mice
yeast
saccharomyc
cerevisia
cerevisia
scizosacchromyc
pomb
pomb
model
organ
studi
basic
cellular
process
eukaryot
cell
includ
transcript
transcript
regul
translat
rna
process
signal
transduct
de
novo
synthesi
amino
acid
nucleotid
import
process
cell
cycl
autophagi
regul
chemic
energi
atp
basic
signal
pathway
eg
map
kinas
cascad
vesicl
traffick
first
discov
yeast
find
yeast
turn
relev
eukaryot
cell
includ
mammal
make
cerevisia
pomb
relev
legitim
system
studi
basic
biochem
physiolog
metabol
genet
process
eukaryot
cell
cerevisia
wide
use
pomb
term
ecoli
eukaryot
cell
yeast
biochem
machineri
similar
mammal
mani
case
mammalian
protein
function
replac
relev
yeast
ortholog
observ
made
yeast
vivo
test
tube
studi
foreign
protein
bacteri
pathogen
factor
mammalian
transcript
factor
steroid
receptor
cerevisia
cell
also
use
reconstitut
mammalian
enzymat
complex
biochem
pathway
ra
regul
map
kinas
even
olfactori
pathway
tast
receptor
activ
enzym
yeast
becom
central
system
biolog
studi
variou
sophist
experiment
tool
develop
avail
yet
model
organ
exampl
onestep
knockout
knockin
process
avail
knockout
librari
nonessenti
gene
abil
harbor
foreign
gene
number
copi
desir
avail
librari
yeast
gene
tag
variou
tag
includ
gfp
furthermor
cerevisia
simpl
singlecel
organ
gene
advanc
bioinformat
systembiolog
tool
power
accur
yeast
importantli
cerevisia
use
studi
viralinduc
apoptosi
viral
mediat
cell
cycl
regul
drug
screen
yet
anoth
type
yeast
pichia
pastori
p
pastori
also
use
research
mainli
effici
express
protein
use
studi
influenza
protein
includ
vrnp
complex
reconstitut
three
compon
viral
polymeras
complex
pa
express
p
pastori
insert
three
gene
chromosom
yeast
cell
abl
express
protein
viral
polymeras
purifi
complex
abl
synthes
rna
vitro
similarli
ha
gene
express
p
pastori
protein
purifi
mous
immun
recombin
ha
found
effect
elicit
high
immun
respons
mice
p
pastori
use
mainli
largescal
protein
product
antibodi
screen
discuss
yeast
model
power
tool
come
assist
influenza
research
sever
way
common
approach
express
viral
protein
yeast
thu
studi
properti
singl
viral
protein
isol
vivo
environ
ha
express
cerevisia
found
ha
protein
glycosyl
membran
bound
also
yeast
cell
express
ha
found
lose
express
plasmid
overtim
phenomenon
may
indic
protein
toxic
yeast
system
use
studi
relationship
within
ha
protein
express
differ
delet
mutant
lack
ctermin
transmembran
anchor
cytoplasm
domain
contain
region
lack
entir
region
glycosyl
stabl
compar
mutant
howev
retain
intracellularli
found
secret
extracellular
medium
hyperglycosyl
demonstr
use
yeast
studi
structurefunct
relationship
import
influenza
protein
properti
mutat
viral
protein
express
via
copper
induc
promot
express
found
toxic
local
nuclear
fraction
similarli
local
nucleu
yeast
toxic
henc
yeast
also
use
studi
subcellular
local
viral
protein
impact
cellular
function
express
ion
channel
yeast
affect
growth
use
revers
channel
inhibitor
caus
increas
transmembran
proton
flux
due
reestablish
proton
gradient
interestingli
influenza
pax
protein
express
yeast
unintend
mutat
appear
pax
pax
mutant
seem
relev
mammalian
system
caus
reduc
antivir
shutoff
activ
test
mammalian
cell
model
prove
use
character
local
function
viral
protein
identifi
potenti
mutat
site
recogn
host
process
affect
viral
protein
seem
howev
full
potenti
yeast
model
understand
viral
protein
har
yet
case
viral
protein
impos
easili
measur
phenotyp
yeast
cell
case
purifi
protein
activ
enzym
system
could
use
isol
new
inhibitor
molecul
revers
phenotyp
activ
via
highthroughput
rapid
effici
screen
part
fujian
strain
viru
na
hna
express
yeast
shown
function
could
inhibit
upon
addit
oseltamivir
zanamivr
suggest
yeastbas
system
function
futur
screen
novel
na
inhibitor
toxic
impos
yeast
express
inde
har
drug
screen
approxim
compound
nation
cancer
institut
divers
set
librari
screen
compound
would
restor
normal
growth
nine
compound
identifi
two
found
toxic
mdck
cell
three
show
activ
influenza
viru
replic
four
three
abl
activ
antivir
mdck
cell
similar
way
cell
infect
viru
viru
lack
equival
screen
took
advantag
growth
inhibit
phenotyp
induc
yeast
express
compar
efficaci
novel
compound
amantadin
led
new
lead
compound
use
yeast
express
novel
compound
identifi
anoth
highthroughput
screen
identifi
spirothizamenthan
compound
use
synthes
deriv
thereof
one
deriv
term
compound
found
inhibit
nativ
importantli
also
protein
amantadineresist
mutant
yeast
system
use
togeth
mdck
cell
test
efficaci
toxic
synthes
arylsulfonamid
compound
elucid
relationship
studi
demonstr
effici
yeast
highthroughput
drug
screen
live
cell
increas
number
potenti
drug
pipelin
yeast
system
could
use
studi
alreadi
known
inhibitor
identifi
mutat
viral
protein
caus
drug
resist
see
hahnenberg
et
al
kurtz
et
al
anoth
import
use
yeast
model
studi
human
protein
known
target
influenza
viru
mani
protein
homolog
yeast
provid
conveni
system
address
function
simpl
eukaryot
deduc
role
infect
process
man
exampl
would
mx
protein
cerevisia
mxrelat
gtpase
known
anoth
protein
high
similar
mx
mutat
analysi
yeast
reveal
key
aspect
protein
structurefunct
similarli
function
reveal
yeast
delet
studi
yeast
could
also
use
establish
entir
influenza
replicon
studi
isol
system
transcript
replic
viral
genom
polyadenyl
translat
control
postgolgi
vesicl
requir
viral
bud
cell
effect
influenza
host
machineri
dramat
involv
interact
plethora
cellular
compon
one
challeng
goal
studi
viru
identifi
direct
target
viral
protein
understand
host
process
affect
protein
specif
inhibitor
target
viralhost
interact
could
develop
approach
reduc
likelihood
resist
sinc
host
gene
unlik
mutat
fast
viral
one
mani
scientist
use
yeast
twohybrid
system
identifi
host
interactor
individu
viral
protein
np
pa
na
sever
studi
appli
twohybrid
system
look
vrnp
complex
main
eight
viral
protein
individu
given
occurr
cell
cultureselect
mutat
use
yeast
altern
determin
drug
suscept
virus
may
prove
use
given
protein
express
intact
less
likelihood
mutat
given
benefit
yeast
biotechnolog
yeast
use
identifi
produc
antiinfluenza
antibodi
vaccin
therapi
sinc
yeast
alreadi
use
gener
novel
influenza
vaccin
seem
untap
potenti
use
yeast
better
elucid
mysteri
influenza
unlik
yeast
fruit
fli
drosophila
melanogast
drosophila
multicellular
organ
serv
therefor
model
studi
intracellular
process
also
address
mechan
develop
differenti
function
tissu
organ
time
similar
yeast
model
drosophila
highli
permiss
genet
manipul
conveni
cheap
handl
laboratori
short
life
span
characterist
made
pivot
model
biolog
varieti
power
experiment
tool
develop
includ
librari
mutant
mechan
tissuespecif
express
protocol
highthroughput
screen
mutant
drug
well
abil
control
gene
express
via
rnai
also
drosophiladeriv
cell
line
avail
allow
scientist
address
biolog
question
tissuecultur
level
parallel
verif
advanc
wholeorgan
level
take
advantag
unusu
properti
fli
combin
effect
experiment
tool
possibl
establish
fli
model
critic
human
diseas
exampl
express
fli
mutat
caus
loss
dopaminerg
neuron
effect
recapitul
essenti
featur
parkinson
diseas
review
aryal
et
al
furthermor
gene
defect
alzheim
diseas
eg
amyloid
tau
conserv
drosophila
allow
studi
simpl
system
conserv
process
respons
metabol
homeostasi
growth
develop
drosophila
mammal
made
excel
model
studi
obes
diabet
age
review
galikova
et
al
inou
et
al
investig
oncogen
pathway
cancer
review
mirzoyan
et
al
enomoto
notabl
concept
tumor
suppressor
discoveri
first
recess
oncogen
establish
drosophila
use
drosophila
system
studi
virus
extens
yet
becom
attract
review
hugh
et
al
common
approach
express
viral
protein
particular
organ
fli
follow
physiolog
phenotyp
patholog
effect
express
protein
epsteinbarr
sar
virus
drosophila
eye
hiv
protein
wing
fat
bodi
led
discoveri
mechanist
aspect
protein
partner
within
host
mani
studi
drosophila
cell
cultur
reveal
mechan
action
viral
protein
approach
use
exampl
protein
hepat
b
hiv
west
nile
virus
cell
cultur
also
serv
largescal
screen
primarili
identif
host
gene
requir
viral
replic
pathogen
virus
found
capabl
replic
within
fli
cell
cultur
even
within
whole
fli
eg
dengu
sindbi
viru
mirna
sirnamedi
silenc
viral
rna
antiviralinduc
autophagi
major
find
obtain
studi
virus
fli
sever
influenza
protein
studi
fli
cultur
cell
whole
fli
influenza
express
wing
eye
caus
wing
defect
total
loss
eye
tissu
male
found
sever
phenotyp
femal
importantli
amantadin
shown
rescu
phenotyp
suggest
drosophila
reliabl
system
antiinfluenza
drug
studi
express
function
ion
channel
transgen
fli
use
screen
mutat
ion
transport
ph
homeostasisrel
gene
host
use
fli
relev
mutat
cross
transgen
fli
found
strongest
modifi
phenotyp
four
gene
encod
differ
subunit
atpas
confirm
result
obtain
specif
fli
mdck
cell
treat
bafilomycin
drug
target
atpas
prior
influenza
infect
reduc
infect
thu
show
transgen
fli
model
use
studi
activ
allow
identif
import
host
target
influenza
drosophila
model
use
report
influenza
abl
suppress
rnasilencingbas
antivir
respons
rsar
host
defens
rna
virus
cellbas
screen
perform
use
drosophila
cell
identifi
new
rna
silenc
suppressor
code
sequenc
gfp
use
infram
start
orf
flock
hous
viru
fhv
obtain
base
previou
observ
fhv
could
inhibit
rna
interfer
rnai
pathway
fhv
infect
use
techniqu
gfp
would
express
rnai
pathway
silenc
observ
cotransfect
plasmid
plasmid
could
rescu
gfp
express
result
show
influenza
function
rna
silenc
suppressor
ntermin
dsrnabind
domain
shown
singl
mutat
increas
rescu
effici
gene
mutant
carri
untranslat
similar
compar
wt
associ
lethal
influenza
viru
use
viral
rna
silenc
principl
five
differ
rna
silenc
inhibitor
includ
express
use
induc
express
system
upon
induct
transgen
tissuespecif
driver
observ
effect
inhibitor
rna
silenc
transgen
fli
later
studi
report
suppress
rnai
mammalian
cell
observ
support
find
drosophila
use
fli
system
studi
function
cdna
strain
express
specif
wing
express
caus
increas
distanc
wing
vein
phenotyp
indic
spatial
broaden
hedgehog
hh
signal
sever
known
mutat
insert
alter
hhmodul
activ
fli
wing
yet
unbias
mutagenesi
screen
provid
new
mutat
locat
effector
domain
reduc
wing
phenotyp
differ
hh
modul
among
variou
viral
strain
exist
udorn
swine
flu
strain
highest
hh
modul
activ
confirm
new
effect
observ
hh
gene
express
alter
influenzainfect
mice
addit
viru
found
pathogen
viru
mice
suggest
lower
level
hh
target
gene
induct
may
protect
influenza
infect
rnai
screen
drosophila
cell
cultur
use
identifi
new
host
gene
requir
viral
replic
demonstr
feasibl
use
system
genom
screen
influenza
notabl
particular
disadvantag
fli
cell
respect
influenza
fact
express
influenza
viru
receptor
sialic
acid
requir
viral
attach
cell
therefor
modifi
viru
fluvsvg
design
ha
na
gene
replac
encod
vesicular
stomat
viru
vsv
glycoprotein
g
modif
influenza
viru
abl
enter
drosophila
cell
screen
host
gene
affect
virusdirect
luciferas
express
carri
fluvsvgrluc
express
renilla
luciferas
gene
rnai
librari
drosophila
gene
gene
total
screen
gene
inhibit
luciferas
express
identifi
two
independ
test
sever
human
homologu
encod
compon
host
machineri
known
involv
life
cycl
viru
eg
endocytosi
pathway
mitochondri
pathway
mrna
nuclear
export
machineri
select
author
show
import
drosophila
system
discoveri
novel
influenza
target
seem
use
drosophila
model
experiment
tool
influenza
studi
infanc
howev
advanc
made
far
use
fli
system
undoubtedli
contribut
realiz
system
relev
model
understand
import
aspect
viral
infect
lead
mani
studi
futur
zebrafish
danio
rerio
belong
cyprinida
famili
famili
carp
goldfish
model
choic
bridg
gap
lower
anim
mammal
vertebr
zebrafish
closer
human
fruit
fli
evolutionari
scale
compar
mice
easier
work
studi
benefit
zebrafish
fulli
develop
immun
system
also
enabl
genet
screen
realtim
visual
seen
marinum
bacteria
speci
use
model
tuberculosi
genu
marinum
zebrafish
given
innat
adapt
immun
zebrafish
use
studi
specif
aspect
immun
develop
initi
day
embryon
develop
exhibit
adapt
immun
marker
full
function
take
week
develop
henc
possibl
studi
innat
immun
respons
exclus
earli
development
week
hostviru
interact
studi
perform
adult
zebrafish
viral
infect
chikungunya
herp
simplex
viru
hepat
c
context
influenza
viru
iav
zebrafish
embryo
report
sialic
acid
enabl
viru
enter
infect
embryo
local
infect
day
postfertil
dpf
embryo
swimbladd
result
zebrafish
mortal
moreov
antivir
gene
found
induc
fish
particularli
zebrafish
virusinduc
interferon
mxa
ortholog
mammalian
mx
protein
follow
infect
iav
microscopi
histopatholog
analysi
zebrafish
found
edema
tissu
destruct
similar
observ
human
infect
hour
infect
necrosi
liver
gill
tissu
also
observ
infect
necrosi
renal
hemopoiet
tissu
moreov
treatment
zanamivir
begin
hpi
found
protect
iav
infect
reduc
mortal
viral
replic
burden
use
gfptag
henc
zebrafish
serv
model
studi
hostviru
interact
drug
screen
dpf
zebrafish
infect
muscl
fiber
damag
observ
muscl
damag
seem
worsen
hpi
compar
hpi
viru
show
viru
infect
skelet
muscl
fish
use
transgen
gfp
zebrafish
gfp
express
control
endothelialspecif
promot
iav
increas
vascular
permeabl
compromis
sarcolemma
integr
also
failur
muscl
fiberecm
adhes
result
muscl
fiber
death
effect
could
due
proinflammatori
innat
immun
signal
cascad
induc
via
nfkb
pathway
suggest
use
nfkb
report
line
nfkb
egfp
nc
use
transgen
fish
tg
bacmpo
gfp
gfp
express
control
neutrophilspecif
myeloperoxidas
mpo
promot
report
neutrophil
infiltr
muscl
tissu
local
unanchor
end
retract
fiber
infect
could
mediat
mapk
rhorock
pkc
pathway
final
use
zebrafish
muscular
dystrophi
model
sapjedmd
infect
zebrafish
found
sever
muscl
degener
almost
everi
muscl
segment
increas
mortal
dpi
compar
pb
inject
mutant
zebrafish
studi
clearli
display
zebrafish
relev
model
influenza
studi
first
line
mechan
immunolog
defens
pathogen
upper
respiratori
tract
nasal
epithelium
holist
understand
viral
replic
dynam
immun
respons
gener
airway
epitheli
cell
complet
yet
also
ciliat
cell
proxim
airway
nose
trachea
import
spread
infect
influenza
viru
studi
primari
human
nasal
epitheli
cell
nec
significantli
assist
understand
influenza
tissu
exampl
normal
tissu
infect
influenza
eotaxin
eosinophilspecif
chemoattract
found
increas
releas
supernat
moreov
cell
found
gener
intracellular
reactiv
oxygen
speci
ro
increas
express
nicotinamid
adenin
dinucleotid
phosphat
oxidas
nox
one
particular
nox
found
signific
dual
oxidas
given
nec
deriv
patient
certain
social
factor
smoke
studi
specif
cell
relat
influenza
nec
deriv
smoker
express
lower
level
antivir
cytokin
increas
proinflammatori
cytokin
result
increas
influenzainduc
cytotox
compar
nec
nonsmok
addit
smoke
appear
reduc
cytokin
express
releas
nec
increas
chemokin
thymic
stromal
lymphopoietin
tslp
level
show
smoke
could
effect
interact
epitheli
cell
immun
cell
note
use
primari
cultur
way
respons
smoker
patient
influenza
infect
could
test
adult
human
nasal
epitheli
stemprogenitor
cell
hnespc
nasal
biopsi
specimen
healthi
subject
patient
allerg
rhiniti
establish
vitro
passag
hnespc
retain
capabl
full
differenti
human
nasal
epithelium
cell
hnec
hnec
infect
viru
progeni
viru
could
detect
hpi
infect
hnec
found
elicit
similar
immun
respons
known
model
interestingli
individu
variat
among
patientderiv
immun
respons
apoptot
cell
death
reflect
differ
respons
viru
popul
infect
hnec
uncov
novel
host
signal
mechan
influenza
viru
stimul
exampl
infect
hnec
result
increas
express
oncostatin
osm
part
type
cytokin
group
upregul
mirna
whose
target
gene
includ
microarray
analysi
infect
hnec
also
reveal
perturb
homeostasi
metabol
pathway
respons
influenza
infect
interest
observ
use
patientderiv
nec
includ
effect
estrogen
compound
nec
deriv
male
femal
donor
show
estrogen
exhibit
protect
effect
upon
infect
femal
male
nec
reflect
hormon
gender
may
affect
individu
respons
influenza
studi
combin
perform
primari
nec
allow
establish
preliminari
model
describ
influenzahost
relationship
nasal
epithelium
new
inform
valuabl
nec
first
come
contact
viru
play
role
viru
transmiss
primari
nhbe
cell
deriv
patient
biopsi
distal
aspect
trachea
carina
normal
upper
respiratori
infect
influenza
known
caus
complic
bronchiti
patient
chronic
condit
elderli
children
henc
nhbe
cell
may
provid
knowledg
influenza
tropism
host
suscept
complic
respons
viru
lower
respiratori
tract
valid
cell
model
influenza
nhbe
cell
compar
mdck
cell
nhbe
cell
found
better
correl
data
term
replic
abil
live
attenu
virus
isol
differ
strain
reflect
nhbe
cell
abl
better
model
viru
replic
infect
variou
viral
strain
human
avian
sourc
human
compar
mdck
cell
histolog
electron
microscopi
studi
reveal
nhbe
morpholog
similar
carina
distal
trachea
conjug
viru
shown
similar
bind
pattern
nhbe
cell
observ
human
respiratori
tissu
replic
kinet
pandem
viru
strain
similar
viru
nhbe
given
nhbe
cell
appropri
studi
viral
cellular
tropism
sever
studi
use
compar
variou
avian
influenza
strain
nhbe
cell
predominantli
display
linkag
sialic
acid
receptor
well
sialic
acid
receptor
sinc
avian
virus
gener
bind
receptor
use
cell
would
provid
better
predict
abil
novel
viral
strain
caus
sever
influenza
human
better
understand
effect
function
viral
protein
infect
revers
geneticsderiv
virus
carri
target
mutat
np
andor
protein
use
revers
genet
perform
show
synergist
effect
np
mutat
infect
nhbe
cell
shown
lower
conduct
chlorid
ion
channel
cystic
fibrosi
transmembran
regul
cftr
may
due
viru
target
cftr
earli
lysosom
degrad
affect
ion
transport
host
case
viral
ha
variou
mutat
affect
viru
abil
infect
cell
seen
viru
viru
pandem
strain
ha
mutat
also
studi
relat
neuraminidas
inhibitor
resist
studi
nhbe
cell
also
show
decreas
neuraminidas
activ
requir
viru
adapt
human
airway
epithelium
studi
ha
na
virus
found
avianlik
surfac
glycoprotein
exhibit
reduc
infect
nhbe
would
requir
humantohuman
transmiss
nhbe
cell
use
provid
better
understand
host
respons
influenza
infect
bronchial
tissu
proteom
studi
perform
human
nhbe
infect
vitro
reveal
signal
pathway
could
import
includ
rhoaassoci
signal
pathway
rhoa
gtpase
regul
actin
cytoskeleton
reduc
hippo
signal
requir
suppress
virusinduc
interferon
product
similarli
proteom
analysi
commerci
obtain
nhbe
cell
lonza
infect
identifi
protein
associ
host
cell
defens
respons
endocytosi
gtpase
activ
influenza
viru
also
found
increas
apoptosi
pyroptosi
well
cmyc
glycolysi
glutaminolysi
nhbe
cell
pediatr
patient
importantli
nhbe
cell
also
use
immedi
translat
cultur
test
clinic
use
exampl
small
molecul
inhibitor
atpas
test
found
inhibit
viral
replic
patient
nhbe
cell
result
confirm
bronchial
explant
obtain
patient
use
prophylact
combin
oseltamivir
reduc
viral
shed
effect
oseltamivir
alon
inhibit
epitheli
infect
addit
infect
nhbe
cell
use
predict
patient
respons
infect
viral
rna
level
cell
taken
older
patient
year
significantli
lower
compar
young
patient
obes
patient
tend
increas
viral
rna
level
lower
cytokin
level
final
nhbe
cell
use
ex
vivo
model
test
efficaci
remov
sialic
acid
inhibit
influenza
infect
given
result
current
reach
phase
ii
clinic
trial
thu
nhbe
cell
isol
patient
rich
sourc
inform
understand
host
factor
affect
influenza
also
point
viral
factor
increas
viru
abil
infect
propag
cell
increas
chanc
viral
bronchiti
importantli
nhbe
cell
unequivoc
tool
predict
patient
respons
drug
treatment
therefor
valuabl
tool
person
treatment
influenza
patient
alveolar
epithelium
make
ga
exchang
portion
lung
main
target
influenza
pneumonia
epithelium
made
two
main
cell
type
known
type
type
ii
cell
alveolar
type
cell
ati
requir
gasexchang
surfac
alveoli
alveolar
type
ii
cell
atii
also
known
type
ii
pneumocyt
synthes
secret
pulmonari
surfact
secret
chemokin
cytokin
involv
innat
immun
lung
differ
cell
tropism
variou
strain
influenza
describ
found
virus
test
could
found
type
ii
type
pneumocyt
cell
use
studi
atii
physiolog
cell
mimic
ati
cell
atii
cell
primari
aec
either
ati
atii
exhibit
normal
cellular
physiolog
also
carri
individu
characterist
patient
deriv
sever
studi
focus
specif
ati
cell
reveal
import
transcript
factor
hostrespons
influenza
induc
transcript
import
antioxid
defens
system
overexpress
protect
cell
infect
decreas
viral
replic
increas
express
may
due
increas
gsh
level
observ
overexpress
studi
viral
effect
specif
mutat
recombin
virus
use
infect
ati
cell
observ
higher
titer
wild
type
viru
lower
level
repres
import
antivir
type
iii
interferon
ati
cell
substitut
shown
caus
increas
viral
replic
mice
guinea
pig
use
ati
cell
prove
mutat
also
increas
viral
replic
human
cell
studi
also
use
atii
cell
isol
human
lung
cell
shown
support
influenza
infect
atii
cell
produc
inflammatori
cytokin
rant
interestingli
found
main
cytokin
produc
infect
atii
cell
aec
shown
primarili
target
virus
anew
aec
differ
donor
differ
suscept
virus
obes
donor
show
significantli
increas
infect
rate
compar
nonobes
donor
link
infect
rate
obes
could
monitor
patientsderiv
primari
cultur
ha
sequenc
studi
substitut
decreas
infect
aec
significantli
could
explain
differ
observ
variou
virus
context
infect
ahong
ahong
could
infect
replic
atilik
atii
cell
use
specif
cell
popul
cocultur
cell
type
differ
host
process
elucid
context
influenza
understand
interact
specif
cell
type
exampl
novel
host
process
atii
cell
activ
epiderm
growth
factor
receptor
egfr
increas
signal
increas
express
cell
adhes
molecul
reduc
secret
surfact
protein
spa
spd
process
known
influenza
infect
studi
aec
confirm
role
process
influenza
summari
primari
human
tissu
cultur
open
new
window
specif
effect
viru
perhap
much
import
patientspecif
effect
patientspecif
respons
drug
treatment
system
thu
great
valu
basic
research
also
immedi
patientspecif
translat
therapeut
valu
although
may
seem
relev
first
glanc
studi
aspect
influenza
infect
yeast
drosophila
zebrafish
provid
knowledg
conceptu
understand
could
obtain
experiment
system
use
primari
cultur
primarili
patientderiv
cultur
also
great
valu
person
medicin
understand
social
behavior
aspect
diseas
spite
understand
spite
proven
achiev
altern
model
still
remain
underutil
fact
drosophila
zebrafish
system
infanc
contribut
field
influenza
research
vast
potenti
hold
help
better
understand
influenza
await
extens
use
model
studi
carri
far
yeast
drosophila
specif
given
viral
protein
specif
host
protein
yet
sever
influenza
protein
express
yeast
fli
fish
addit
whole
viru
yet
reconstitut
yeast
nevertheless
systemat
largescal
experi
aim
look
entir
process
viral
infect
model
organ
perform
predict
lead
way
wider
use
altern
system
may
ultim
lead
deeper
understand
viru
pathogen
better
treatment
vaccin
tradit
model
influenza
advantag
use
believ
altern
model
must
use
parallel
tabl
show
advantag
altern
model
anticip
mani
molecular
mechan
influenza
new
therapi
longstand
maladi
reveal
use
